Is there an age cutoff for when to avoid FOLFIRINOX in older patients with pancreatic cancer?

The original Conroy trial had a maximum age of 75 years old; but then the recent PRODIGE 24/CCTG PA.6 adjuvant trial increased the age limit up to 79. I think this reflects the idea that there are still good performing elderly patients who may well tolerate FOLFIRINOX, and I have treated patients in...